| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
in Lung Cancer Patients and Controls1
Institute of Clinical Pharmacology, Klinikum Steglitz, Free University Berlin, Hindenburgdamm 30, D-1000 Berlin 45, Germany
Glutathione S-transferase class µ (GSTM1) is known to detoxify certain carcinogens or their activated metabolites. In a previous study using phenotyping methods, individuals genetically devoid of this enzyme activity were significantly overrepresented among lung cancer patients compared to controls, suggesting that this trait is a risk factor for lung cancer. Here, GST class µ status has been determined both pheno- and genotypically, i.e., (a) by ex vivo measurement of trans-stilbene oxide conjugation in lymphocytes, (b) by GSTM1 quantification in blood using an immunoassay, and (c) by the application of polymerase chain reaction to genomic DNA with characterization of an inactivating mutation responsible for the null allele and a G/C single base allelic variance corresponding to the polymorphism of GSTM1 isoenzymes µ and 
, respectively. One hundred seventeen lung cancer patients and 155 control patients were studied. The two groups were of German origin and were similar with respect to age, sex, smoking history, and catchment area. In about 97% of cases, the three methods of assigning activity type of GSTM1 gave corresponding results. By genotype, 55 of 117 lung cancer patients (47.0%) and 73 of 155 control patients (47.1%) were GSTM1 active. The control group was confirmed by analysis of GSTM1 genotype in 200 further, independently studied reference patients; 101 of them were GSTM1 active (50.5%). Thus, the hypothesis of heritable GSTM1 deficiency as a host factor predisposing to lung cancer proved inappropriate. Detailed analysis of subgroups with respect to smoking habits, age, and sex failed to reveal an impact of GST class µ genotype on lung cancer risk. Among the total of 272 patients studied, 36 individuals carried at least one allele; however, no unexpected frequency distribution was observed.
1 This work is partly supported by the Foundation on Behavior and Environment, Bonn, Germany.
2 To whom requests for reprints should be addressed, at Institut für Klinische Pharmakologie, Klinikum Steglitz, Hindenburgdamm 30, D-1000 Berlin 45, Germany.
Received 8/ 6/92. Accepted 12/21/92.
This article has been cited by other articles:
|
|
 |
|
  I. A. Hakim, H.-H. S. Chow, and R. B. Harris Green Tea Consumption Is Associated with Decreased DNA Damage among GSTM1-Positive Smokers Regardless of Their hOGG1 Genotype J. Nutr., August 1, 2008; 138(8): 1567S - 1571S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis Am. J. Epidemiol., April 1, 2008; 167(7): 759 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.E. Moore, P. Brennan, S. Karami, R.J. Hung, C. Hsu, P. Boffetta, J. Toro, D. Zaridze, V. Janout, V. Bencko, et al. Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study Carcinogenesis, September 1, 2007; 28(9): 1960 - 1964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. KAVISHE, J. B. KOENDERINK, M. B.B. MCCALL, W. H.M. PETERS, B. MULDER, C. C. HERMSEN, R. W. SAUERWEIN, F. G.M. RUSSEL, and A. J.A.M. VAN DER VEN SEVERE PLASMODIUM FALCIPARUM MALARIA IN CAMEROON: ASSOCIATED WITH THE GLUTATHIONE S-TRANSFERASE M1 NULL GENOTYPE Am J Trop Med Hyg, November 1, 2006; 75(5): 827 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Moore, W.-Y. Huang, N. Chatterjee, M. Gunter, S. Chanock, M. Yeager, B. Welch, P. Pinsky, J. Weissfeld, and R. B. Hayes GSTM1, GSTT1, and GSTP1 Polymorphisms and Risk of Advanced Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1823 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.M.J. van der Logt, S.M. Bergevoet, H.M.J. Roelofs, Z. van Hooijdonk, R.H.M. te Morsche, T. Wobbes, J.B. de Kok, F.M. Nagengast, and W.H.M. Peters Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk Carcinogenesis, December 1, 2004; 25(12): 2407 - 2415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Hsieh, C.-C. Chang, F.-J. Tsai, C.-C. Lin, J.-M. Chen, and C.-H. Tsai Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis Mol. Hum. Reprod., October 1, 2004; 10(10): 713 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-K. Alexandrie, F. Nyberg, M. Warholm, and A. Rannug Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 908 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Hakim, R. B. Harris, H-H. S. Chow, M. Dean, S. Brown, and I. U. Ali Effect of a 4-Month Tea Intervention on Oxidative DNA Damage among Heavy Smokers: Role of Glutathione S-Transferase Genotypes Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, P. Boffetta, J. Brockmoller, D. Butkiewicz, I. Cascorbi, M. L. Clapper, S. Garte, A. Haugen, A. Hirvonen, S. Anttila, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis Carcinogenesis, May 1, 2003; 24(5): 875 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J de Jong, E M J van der Logt, A van Schaik, H M J Roelofs, W H M Peters, and T H J Naber Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase Gut, April 1, 2003; 52(4): 547 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Benhamou, W. J. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M. L. Clapper, A. Daly, V. Dolzan, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk Carcinogenesis, August 1, 2002; 23(8): 1343 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Engel, E. Taioli, R. Pfeiffer, M. Garcia-Closas, P. M. Marcus, Q. Lan, P. Boffetta, P. Vineis, H. Autrup, D. A. Bell, et al. Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review Am. J. Epidemiol., July 15, 2002; 156(2): 95 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Ford, Y. Li, M. M. O'Sullivan, R. Demopoulos, S. Garte, E. Taioli, and P. W. Brandt-Rauf Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans Carcinogenesis, November 1, 2000; 21(11): 1971 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chastagner, J. L. Merlin, C. Marchal, S. Hoffstetter, M. Barberi-Heyob, G. Vassal, and A. Duprez In Vivo Potentiation of Radiation Response by Topotecan in Human Rhabdomyosarcoma Xenografted into Nude Mice Clin. Cancer Res., August 1, 2000; 6(8): 3327 - 3333. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. L. M. ZUSTERZEEL, W. VISSER, W. H. M. PETERS, H. W. M. J. MERKUS, W. L. D. M. NELEN, and E. A. P. STEEGERS Polymorphism in the Glutathione S-transferase P1 Gene and Risk for Preeclampsia Obstet. Gynecol., July 1, 2000; 96(1): 50 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L.M. Zusterzeel, W. L.D.M. Nelen, H. M.J. Roelofs, W. H.M. Peters, H. J. Blom, and E. A.P. Steegers Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss Mol. Hum. Reprod., May 1, 2000; 6(5): 474 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Guengerich Metabolism of chemical carcinogens Carcinogenesis, March 1, 2000; 21(3): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, L. Mayer, A. Kopp-Schneider, I. Roots, and H. Bartsch Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism Carcinogenesis, January 1, 2000; 21(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Woodson, C. Stewart, M. Barrett, N. K. Bhat, J. Virtamo, P. R. Taylor, and D. Albanes Effect of Vitamin Intervention on the Relationship between GSTM1, Smoking, and Lung Cancer Risk Among Male Smokers Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 965 - 970. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Houlston Glutathione S-Transferase M1 Status and Lung Cancer Risk: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., August 1, 1999; 8(8): 675 - 682. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. C. Stroombergen and R. H Waring Determination of glutathione S-transferase {micro} and {tau} polymorphisms in neurological disease Human and Experimental Toxicology, March 1, 1999; 18(3): 141 - 145. [Abstract] [PDF]
|
|
|
|
 |
|
 E. M. M. van Lieshout, H. M. J. Roelofs, S. Dekker, C. J. J. Mulder, T. Wobbes, J. B. M. J. Jansen, and W. H. M. Peters Polymorphic Expression of the Glutathione Polymorphic Expression of the Glutathione S-Transferase P1 Gene and Its Susceptibility to Barrett's Esophagus and Esophageal Carcinoma Cancer Res., February 1, 1999; 59(3): 586 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. McLellan, M. Oscarson, A.-K. Alexandrie, J. Seidegård, D. A. P. Evans, A. Rannug, and M. Ingelman-Sundberg Characterization of a Human Glutathione S-Transferase µ Cluster Containing a Duplicated GSTM1 Gene that Causes Ultrarapid Enzyme Activity Mol. Pharmacol., December 1, 1997; 52(6): 958 - 965. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
